XML 25 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Cash collections from financial royalty assets $ 2,507,236 $ 2,315,854 $ 2,121,923
Cash collections from intangible royalty assets 72,943 151,158 143,753
Other royalty cash collections 69,891 44,123 18,305
Distributions from equity method investees 39,142 34,384 42,334
Interest received 24,982 3,135 7,704
Derivative collateral received 0 34,660 45,252
Derivative collateral posted 0 (34,660) 0
Termination payments on derivative instruments 0 (16,093) (35,448)
Development-stage funding payments - ongoing (2,106) (6,876) (20,479)
Development-stage funding payments - upfront and milestone (175,000) (193,208) (5,810)
Payments for operating and professional costs (222,969) (184,511) (179,709)
Interest paid (170,139) (130,430) (103,196)
Net cash provided by operating activities 2,143,980 2,017,536 2,034,629
Cash flows from investing activities:      
Distributions from equity method investees 0 523 15,084
Investments in equity method investees (9,896) (34,855) (40,155)
Purchases of equity securities (87,785) (135,134) (50,000)
Proceeds from equity securities 211,158 115,957 384,840
Purchases of available for sale debt securities (479,559) (70,441) 0
Proceeds from available for sale debt securities 542,044 62,500 3,000
Purchases of marketable securities (234,869) (1,196,579) (1,705,283)
Proceeds from sales and maturities of marketable securities 792,341 1,597,851 815,440
Acquisitions of financial royalty assets (1,741,640) (2,191,502) (2,182,246)
Acquisitions of other financial assets (21,215) 0 0
Milestone payments 0 (18,600) 0
Net cash used in investing activities (1,029,421) (1,870,280) (2,759,320)
Cash flows from financing activities:      
Distributions to shareholders/unitholders 0 0 (285,353)
Distributions to legacy non-controlling interests - royalty receipts (441,963) (479,604) (543,952)
Distributions to legacy non-controlling interests - other (31,301) (20,367) (67,654)
Distributions to continuing non-controlling interests (144,115) (133,433) (113,481)
Dividends to shareholders (333,322) (285,184) (112,490)
Contributions from legacy non-controlling interests - R&D 1,059 7,339 8,482
Contributions from non-controlling interests - other 6,133 36,874 58,957
Scheduled repayments of long-term debt 0 0 (94,200)
Repayments of long-term debt 0 0 (11,116,196)
Proceeds from issuance of long-term debt, net of discount 0 1,272,533 11,891,030
Debt issuance costs and other (1,347) (13,046) (46,715)
Proceeds from issuance of Class A ordinary shares upon IPO, net of offering costs 0 0 1,908,744
Net cash (used in)/provided by financing activities (944,856) 385,112 1,487,172
Net change in cash and cash equivalents 169,703 532,368 762,481
Cash and cash equivalents, beginning of year 1,541,048 1,008,680 246,199
Cash and cash equivalents, end of year $ 1,710,751 $ 1,541,048 $ 1,008,680